Medical Feed Additives Market Report 2026

The medical feed additives market size has grown strongly in recent years. It will grow from $16.09 billion in 2025 to $17.23 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to intensification of livestock farming, rising incidence of animal diseases, increasing demand for higher feed efficiency, widespread use of antibiotic feed additives, growth of commercial poultry and swine production.

The medical feed additives market size is expected to see strong growth in the next few years. It will grow to $22.71 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to regulatory restrictions on antibiotic usage, rising demand for safe and quality animal protein, expansion of aquaculture farming, advancements in animal nutrition research, increasing focus on preventive animal healthcare. Major trends in the forecast period include shift toward non-antibiotic medical feed additives, rising adoption of probiotics and prebiotics in feed, increased focus on immune-enhancing feed formulations, growing demand for species-specific feed additives, expansion of functional amino acids and enzyme usage.

The growth in livestock farm sizes is expected to propel the medical feed additives market in the coming years. A livestock farm is an agricultural operation that raises animals such as cattle, sheep, pigs, poultry, and occasionally horses or goats for purposes including meat production, egg laying, dairy products, and other animal-derived outputs. The expansion of livestock farms has increased the need for feed additives that improve feed efficiency and support animal health. Factors contributing to this trend include rising demand for livestock-based products, the need to enhance feed efficiency, growing focus on animal health, stringent regulations governing meat quality, increased commercialization of livestock farming, and geographic expansion of farming operations. For example, in February 2024, according to the United States Department of Agriculture, a U.S.-based federal agency, the average farm size in 2023 reached 464 acres, up from 463 acres in the previous year. Therefore, the expansion of livestock farm sizes is driving the growth of the medical feed additives market.

Major companies operating in the medical feed additives market are emphasizing innovation in livestock feed formulations to better address evolving customer requirements. Livestock feed formulation involves designing nutritionally balanced diets by selecting and combining feed ingredients in appropriate proportions to meet animals’ dietary needs. The objective of feed formulation is to deliver a cost-effective, palatable, and nutritionally adequate diet that supports optimal growth, health, and productivity. For instance, in June 2023, Evonik Industries AG, a Germany-based chemical company, introduced an enhanced formulation of Biolys, a widely used lysine source for animal nutrition. The new Biolys formulation contains 62.4% L-lysine (equivalent to an 80% ratio to lysine HCl), compared with 60% L-lysine (a 77% ratio to lysine HCl) in the earlier version. In addition, it includes beneficial fermentation by-products that provide extra energy and minerals, supporting livestock such as pigs and poultry. This updated formulation enables producers to meet animals’ essential L-lysine requirements more efficiently. Biolys is manufactured through fermentation, in which microorganisms convert maize-derived dextrose into L-lysine, which is then combined with nutrient-rich biomass in granular form.

In April 2024, Phibro Animal Health Corporation, a U.S.-based diversified animal health and nutrition company, acquired the medicated feed additive product portfolio and certain water-soluble products from Zoetis Inc. for $350 million. Through this acquisition, Phibro aimed to broaden its product range and reinforce its position in the global animal health and nutrition market by adding a complementary portfolio of medicated feed additives and associated assets. Zoetis Inc. is a U.S.-based animal health company specializing in the development and commercialization of medicines, vaccines, diagnostics, and related technologies for both livestock and companion animals.

Major companies operating in the medical feed additives market are Zoetis Inc., Cargill Incorporated, CHS Inc., Purina Animal Nutrition LLC, Archer Daniels Midland Company, Adisseo France Sas, Alltech Inc., Hipro Animal Nutrition, BASF SE, Biostadt India Limited, Zagro Co. Ltd., Koninklijke DSM NV, Novozymes AS, Nutreco N.V., Evonik Industries AG, Diamond V, Neovia Logistics Holdings Ltd., Delacon Biotech Nik GmbH, ForFarmers N.V, Kemin Industries, DuPont de Nemours Inc., Solvay SA, Ajinomoto Co. Inc., Chr. Hansen A/S, Red Nucleus, HI-PRO Feeds, Novus International Inc., Provimi Holding B.V., Lallemand Inc., Pancosma S.A., Trouw Nutrition International B.V., Anpario plc, Biovet JSC, BioResource International Inc.

North America was the largest region in the medical feed additives market in 2025. Asia-Pacific was the second-largest region in the medical feed additives market. The regions covered in the medical feed additives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical feed additives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have moderately affected the medical feed additives market by increasing the cost of imported antibiotics, enzymes, probiotics strains, and specialty amino acids used in feed formulations. These impacts are most visible in antibiotic and probiotic segments, with Asia-Pacific and Latin America being highly affected due to dependence on cross-border sourcing of feed ingredients. Poultry and aquaculture sectors face higher feed costs, impacting profit margins for producers. However, tariffs are also driving local manufacturing, regional sourcing of additives, and innovation in cost-effective non-antibiotic feed solutions, supporting long-term market stability.

The medical feed additives market research report is one of a series of new reports that provides medical feed additives market statistics, including medical feed additives industry global market size, regional shares, competitors with a medical feed additives market share, detailed medical feed additives market segments, market trends and opportunities, and any further data you may need to thrive in the medical feed additives industry. This medical feed additives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical feed additives are substances incorporated into animal feed to promote health, prevent diseases, and improve the overall productivity of livestock. These additives support faster growth, enhance immune function, aid digestion, and ensure optimal nutrient absorption in animals. Commonly used in agriculture and animal husbandry, they help maintain animal health, improve feed efficiency, and prevent the spread of infections. Regulatory bodies closely monitor their use to ensure safety and prevent issues like antibiotic resistance in both animals and humans.

The additives primarily encompass antioxidants, antibiotics, probiotics, prebiotics, enzymes, and amino acids. Antioxidants encompass a spectrum of nutritional feed additives administered to animals. These products come in various forms, including supplements, concentrates, premixed feeds, and base mixes. These products are available in diverse classes such as typing a, type b, and type c, catering to varied livestock including ruminants, poultry, swine, and aquaculture.

The medical feed additives market consists of sales of digestibility enhancers, coccidiostats and histomonostats, antimicrobials, and growth hormones. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.